mhurhangee/ep-ind-claims huggingface dataset:
A method of characterizing and/or identifying a microorganism, comprising: (a) obtaining a test sample known to contain or that may contain microorganisms; (b) layering the test sample over a density cushion in a container, wherein said density cushion has a homogenous density of from 1.025 to 1.120 g/ml; (c) adding an identifier agent to said test sample and/or said density cushion; (d) centrifuging said container to separate microorganisms from other components of said test sample, said microorganisms passing through said density cushion to form a pellet of microorganisms at the bottom of said container; (e) interrogating said pellet and said identifier agent using optical spectroscopy to produce measurements which characterize and/or identify the microorganisms, wherein said optical spectroscopy occurs while said pellet remains in said container; and (f) characterizing and/or identifying the microorganisms in the pellet based on the produced measurements and the presence or absence of said identifier agent or a metabolized form of said identifier agent in the pellet, wherein said microorganisms are characterized into one or more classification models selected from the group consisting of Gram Groups, Clinical Gram Groups, Therapeutic Groups, and Functional Groups and/or wherein said microorganisms are identified to the species level. (a) obtaining a test sample known to contain or that may contain microorganisms; (b) layering the test sample over a density cushion in a container, wherein said density cushion has a homogenous density of from 1.025 to 1.120 g/ml; (c) adding an identifier agent to said test sample and/or said density cushion; (d) centrifuging said container to separate microorganisms from other components of said test sample, said microorganisms passing through said density cushion to form a pellet of microorganisms at the bottom of said container; (e) interrogating said pellet and said identifier agent using optical spectroscopy to produce measurements which characterize and/or identify the microorganisms, wherein said optical spectroscopy occurs while said pellet remains in said container; and (f) characterizing and/or identifying the microorganisms in the pellet based on the produced measurements and the presence or absence of said identifier agent or a metabolized form of said identifier agent in the pellet, wherein said microorganisms are characterized into one or more classification models selected from the group consisting of Gram Groups, Clinical Gram Groups, Therapeutic Groups, and Functional Groups and/or wherein said microorganisms are identified to the species level.
A delivery catheter (1, 30, 60, 70, 80, 100, 110, 200, 140, 300) comprising:- a catheter shaft (2, 4) defining a reception space for a self expanding stent; the catheter shaft comprising a proximal shaft portion and a distal pod, the pod, defining the reception space; an operating element extending through the catheter shaft (2, 4) for engagement with a stent in the reception space to facilitate deployment of the stent from within the reception space upon movement of the catheter shaft (2, 4) relative to the operating element (3, 6) from a delivery configuration to a deployment configuration; along at least a portion of the length of the operating element, the cross-sectional area of the operating element being small relative to the cross-sectional area of the catheter shaft (2, 4); characterised in that the catheter shaft comprises a mounting piece for attaching the pod to the proximal shaft portion, the mounting piece having a guidewire lumen for passage of a guidewire and a lumen for passage of the operating element, the cross sectional area of the operating element being small relative the cross sectional area of the catheter shaft (2, 4) in the region of the mounting piece. a catheter shaft (2, 4) defining a reception space for a self expanding stent; the catheter shaft comprising a proximal shaft portion and a distal pod, the pod, defining the reception space; an operating element extending through the catheter shaft (2, 4) for engagement with a stent in the reception space to facilitate deployment of the stent from within the reception space upon movement of the catheter shaft (2, 4) relative to the operating element (3, 6) from a delivery configuration to a deployment configuration; along at least a portion of the length of the operating element, the cross-sectional area of the operating element being small relative to the cross-sectional area of the catheter shaft (2, 4); characterised in that the catheter shaft comprises a mounting piece for attaching the pod to the proximal shaft portion, the mounting piece having a guidewire lumen for passage of a guidewire and a lumen for passage of the operating element, the cross sectional area of the operating element being small relative the cross sectional area of the catheter shaft (2, 4) in the region of the mounting piece.
Method for the correction of a time-dependent measurement signal, generated by means of a motor (1.1), coupled on the output side to a transmission (1.2), with respect to the effect of a variable operational load and a variable rpm, in which the following method steps are carried out: a) tapping a measurement signal dependent on the torque of the motor-transmission unit, b) generating a direct component-free useful signal from the measurement signal, c) determining, in intervals, effective values from the measurement signal, d) generating a load-corrected useful signal by means of dividing in intervals the direct component-free useful signal by the interval-specific effective values, e) time-resolved determining of the rotational frequency (f) of the motor from the measurement signal, f) scaling the load-corrected useful signal to a medium rotational frequency for the generation of a corrected measurement signal (M corr) with the aid of the determined rotational frequency (f), in that individual periods of the useful signal which exhibit a higher frequency are extended, while periods with a lower rotational frequency are compressed, and g) using the corrected measurement signal to detect errors in the motor-transmission unit. a) tapping a measurement signal dependent on the torque of the motor-transmission unit, b) generating a direct component-free useful signal from the measurement signal, c) determining, in intervals, effective values from the measurement signal, d) generating a load-corrected useful signal by means of dividing in intervals the direct component-free useful signal by the interval-specific effective values, e) time-resolved determining of the rotational frequency (f) of the motor from the measurement signal, f) scaling the load-corrected useful signal to a medium rotational frequency for the generation of a corrected measurement signal (M corr) with the aid of the determined rotational frequency (f), in that individual periods of the useful signal which exhibit a higher frequency are extended, while periods with a lower rotational frequency are compressed, and g) using the corrected measurement signal to detect errors in the motor-transmission unit.
An electric brake device comprising an electric motor, a linear motion mechanism configured to convert a rotary motion of the electric motor to a linear motion and output the linear motion, and a control device, which applies an operating quantity to the electric motor, for controlling a braking force generated by the linear motion mechanism, characterized in that the control device is configured to detect a frequency of one of a control command value, an operating quantity and a controlled variable, and to limit the operating quantity according to a predetermined parameter if the frequency is higher than a predetermined frequency threshold value, and the control device is configured to adjust a value of the parameter such that the higher the frequency, the smaller value the operating quantity is limited to.
Method for producing an edge structure of a semiconductor component comprising the following steps: - Providing a semiconductor body, wherein the semiconductor body comprises the following: - at least two main surfaces (102, 112), each having an edge (104, 114), and - at least one edge region (106, 116, 126) adjoining at least one of the edges (104, 114), - Applying a chemical etchant while simultaneously rotating the semiconductor body in a targeted manner on at least one edge region (106, 116, 126) of the semiconductor body in such a way that the etching effect is limited to the edge region (106, 116, 126), - characterized in that applying the etchant is begun at the radially inner section and the application location is altered radially outwards during the etching process. - Providing a semiconductor body, wherein the semiconductor body comprises the following: - at least two main surfaces (102, 112), each having an edge (104, 114), and - at least one edge region (106, 116, 126) adjoining at least one of the edges (104, 114), - at least two main surfaces (102, 112), each having an edge (104, 114), and - at least one edge region (106, 116, 126) adjoining at least one of the edges (104, 114), - Applying a chemical etchant while simultaneously rotating the semiconductor body in a targeted manner on at least one edge region (106, 116, 126) of the semiconductor body in such a way that the etching effect is limited to the edge region (106, 116, 126), - characterized in that applying the etchant is begun at the radially inner section and the application location is altered radially outwards during the etching process.
A pharmaceutical composition comprising 5-{[(2S,5R)-2,5-Dimethyl-4-(tetrahydro-2H-pyran-4-ylmethyl)piperazin-1-yl]carbonyl}-N-(5-fluoro-2-methylpyrimidin-4-yl)-6,6-dimethyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-amine, or a pharmaceutically acceptable salt thereof, for use in a method of treating an autoimmune or alloimmune disease in a patient, wherein the autoimmune or alloimmune disease is: rheumatoid arthritis; multiple sclerosis; inflammatory bowel disease; optic neuritis; neuromyelitis optica; Sjögren's syndrome; systemic scleroderma; ankylosing spondylitis; autoimmune hepatitis; graft vs host disease; or organ transplant rejection. rheumatoid arthritis; multiple sclerosis; inflammatory bowel disease; optic neuritis; neuromyelitis optica; Sjögren's syndrome; systemic scleroderma; ankylosing spondylitis; autoimmune hepatitis; graft vs host disease; or organ transplant rejection.
Continuous extrusion process for preparing cold water swelling phosphate-cross-linked starch derivatives, characterised in that the process consists of the subsequent steps of - gelatinising an alkaline starch in a first zone in the extruder; - adding of POCl 3 as cross-linking reagent in a second zone in the extruder; - cross-linking the obtained gelatinised starch by means of the POCl 3 in the second and third zone (11, 12) in the extruder, and - neutralising the obtained cross-linked gelatinised starch that is present in a fourth zone in the extruder; - recovering the obtained cross-linked, gelatinised starch in a fifth zone in the extruder. - gelatinising an alkaline starch in a first zone in the extruder; - adding of POCl 3 as cross-linking reagent in a second zone in the extruder; - cross-linking the obtained gelatinised starch by means of the POCl 3 in the second and third zone (11, 12) in the extruder, and - neutralising the obtained cross-linked gelatinised starch that is present in a fourth zone in the extruder; - recovering the obtained cross-linked, gelatinised starch in a fifth zone in the extruder.
A medical device lead (14, 16) comprising: one or more electrodes; a lead conductor (62, 64; 72; 82) electrically coupled to at least one of the one or more electrodes, the lead conductor (62, 64; 72; 82) configured to deliver electrical signals to at least one of the one or more electrodes; and characterised by a sacrificial conductor (66, 68; 76; 86, 88) extending through the lead body adjacent to the lead conductor (62, 64; 72; 82), the sacrificial conductor (66, 68; 76; 86, 88) configured to fail at lower stress than the lead conductor (62, 64; 72; 82). one or more electrodes; a lead conductor (62, 64; 72; 82) electrically coupled to at least one of the one or more electrodes, the lead conductor (62, 64; 72; 82) configured to deliver electrical signals to at least one of the one or more electrodes; and characterised by a sacrificial conductor (66, 68; 76; 86, 88) extending through the lead body adjacent to the lead conductor (62, 64; 72; 82), the sacrificial conductor (66, 68; 76; 86, 88) configured to fail at lower stress than the lead conductor (62, 64; 72; 82).
A piezoelectric element, comprising: a first electrode provided at a base body; a piezoelectric layer provided at the first electrode and containing a composite oxide that contains potassium, sodium, and niobium and that has a perovskite structure; and a second electrode provided at the piezoelectric layer, wherein the first electrode is a platinum layer, the first electrode has an average crystal grain diameter of 200 nm or more; and characterised in that the first electrode is preferentially oriented to, and in that the first electrode has a surface roughness Rq of 2.20 nm or more. a first electrode provided at a base body; a piezoelectric layer provided at the first electrode and containing a composite oxide that contains potassium, sodium, and niobium and that has a perovskite structure; and a second electrode provided at the piezoelectric layer, wherein the first electrode is a platinum layer, the first electrode has an average crystal grain diameter of 200 nm or more; and characterised in that the first electrode is preferentially oriented to, and in that the first electrode has a surface roughness Rq of 2.20 nm or more.
A reinforced tissue graft comprising: a first membrane comprising a placental tissue having a first side and a second side; a biocompatible mesh having a plurality of pores and a first side and a second side, wherein the first side of the biocompatible mesh is adjacent to the second side of the first membrane; and a second membrane comprising a placental tissue having a first side and a second side, wherein the first side of the second membrane is adjacent to the second side of the biocompatible mesh; optionally one or more additional placental tissues on either side of the biocompatible mesh, wherein at least one of the first membrane, the second membrane, or the one or more additional placental tissues comprise modified amnion having an epithelial cell layer, or an intact fibroblast cellular layer; and wherein the pores are of sufficient size to allow self-adherence of the placental tissue layers. a first membrane comprising a placental tissue having a first side and a second side; a biocompatible mesh having a plurality of pores and a first side and a second side, wherein the first side of the biocompatible mesh is adjacent to the second side of the first membrane; and a second membrane comprising a placental tissue having a first side and a second side, wherein the first side of the second membrane is adjacent to the second side of the biocompatible mesh; optionally one or more additional placental tissues on either side of the biocompatible mesh, wherein at least one of the first membrane, the second membrane, or the one or more additional placental tissues comprise modified amnion having an epithelial cell layer, or an intact fibroblast cellular layer; and wherein the pores are of sufficient size to allow self-adherence of the placental tissue layers.
An air conditioner comprising: a supercooling heat exchanger for supercooling or evaporating refrigerant; a compressor (110, 112) for compressing refrigerant; an injection flow channel (158a, 158b) through which the evaporated refrigerant flows into the compressor (110, 112); an injection valve (159a, 159b) for opening and closing the injection flow channel; an oil separator (120, 122) for separating oil from refrigerant discharged from the compressor (110, 112); a recovery flow channel (116, 116a) configured to recover oil from the oil separator (120, 122) to the compressor (110, 112); and an oil injection line, which communicates at one end thereof with the oil separator and communicates at the other end thereof with the injection flow channel so as to guide the oil separated by the oil separator toward the injection flow channel, the oil injection line branched from the first recovery flow channel, wherein the oil separated by the oil separator selectively flows into the compressor through the oil injection line and the injection flow channel in accordance with a mode of operation of the air conditioner, wherein one end of the injection flow channel (158a, 158b) communicates with the compressor (110, 112), and the other end of the injection flow channel (158a, 158b) communicates with the supercooling heat exchanger, and the injection flow channel is used as a flow channel through which gas-phase refrigerant flows into the compressor in a heating operation, and as a flow channel through which the oil separated by the oil separator flows into the compressor in a cooling operation. a supercooling heat exchanger for supercooling or evaporating refrigerant; a compressor (110, 112) for compressing refrigerant; an injection flow channel (158a, 158b) through which the evaporated refrigerant flows into the compressor (110, 112); an injection valve (159a, 159b) for opening and closing the injection flow channel; an oil separator (120, 122) for separating oil from refrigerant discharged from the compressor (110, 112); a recovery flow channel (116, 116a) configured to recover oil from the oil separator (120, 122) to the compressor (110, 112); and an oil injection line, which communicates at one end thereof with the oil separator and communicates at the other end thereof with the injection flow channel so as to guide the oil separated by the oil separator toward the injection flow channel, the oil injection line branched from the first recovery flow channel, wherein the oil separated by the oil separator selectively flows into the compressor through the oil injection line and the injection flow channel in accordance with a mode of operation of the air conditioner, wherein one end of the injection flow channel (158a, 158b) communicates with the compressor (110, 112), and the other end of the injection flow channel (158a, 158b) communicates with the supercooling heat exchanger, and the injection flow channel is used as a flow channel through which gas-phase refrigerant flows into the compressor in a heating operation, and as a flow channel through which the oil separated by the oil separator flows into the compressor in a cooling operation.
An isocyanate-functional silicone-polyether copolymer having the following formula: wherein each R 1 is an independently selected substituted or unsubstituted hydrocarbyl group having from 1 to 18 carbon atoms; subscript a is 0 or 1; D is a divalent hydrocarbon group having from 2 to 18 carbon atoms; Y' is a polyether moiety; and X is an isocyanate moiety having at least one isocyanate functional group.
Fluxing composition, comprising: - 50 - 99 wt. % of at least one hydrocarbon oil having an isoparaffin content of 90 - 100 wt. %, a normal paraffin content of 0 - 10 wt. %, and a content greater than or equal to 90 wt. % of carbon of biological origin relative to the total weight of the hydrocarbon oil, - and 1 - 50 wt. % of at least one compound of plant or animal origin selected from C 6 -C 24 fatty acids in acid, ester, or amide form, relative to the total weight of the fluxing composition. - 50 - 99 wt. % of at least one hydrocarbon oil having an isoparaffin content of 90 - 100 wt. %, a normal paraffin content of 0 - 10 wt. %, and a content greater than or equal to 90 wt. % of carbon of biological origin relative to the total weight of the hydrocarbon oil, - and 1 - 50 wt. % of at least one compound of plant or animal origin selected from C 6 -C 24 fatty acids in acid, ester, or amide form,
A method for culturing cells, comprising the steps of: a) providing a cell culture article having a surface coated with a composition comprising: (i) a hydrophilic polymer, wherein the hydrophilic polymer is covalently linked to the surface of the cell culture article, and (ii) polyelectrolyte multilayers, wherein the hydrophilic polymer is in direct contact with a polycation or a polyanion of the polyelectrolyte multilayers; b) seeding cells on the coated surface; and c) culturing the cells under a suitable medium for a sufficient period of time to form one or more single-cell-derived spheroids, wherein the one or more spheroids are generated via single cell proliferation. a) providing a cell culture article having a surface coated with a composition comprising: (i) a hydrophilic polymer, wherein the hydrophilic polymer is covalently linked to the surface of the cell culture article, and (ii) polyelectrolyte multilayers, wherein the hydrophilic polymer is in direct contact with a polycation or a polyanion of the polyelectrolyte multilayers; b) seeding cells on the coated surface; and c) culturing the cells under a suitable medium for a sufficient period of time to form one or more single-cell-derived spheroids, wherein the one or more spheroids are generated via single cell proliferation.
A flexible RAM loading device comprising: - a shift register comprising a first data section, a second data section, and a first shift-register selection bit (302H/302I); - a test register comprising a data section and a first test-register selection bit, the first test-register selection bit (304E/304F) being loaded from the first shift-register selection bit (302H/302I); and - a first shift-register multiplexer comprising: - a first input coupled with an output of the first data section; - a second input coupled with a first external data pin; - an output coupled with an input of the second data section; and - a selection input coupled with the first test-register selection bit, the output of the first shift-register multiplexer depending on the first test-register selection bit. - a shift register comprising a first data section, a second data section, and a first shift-register selection bit (302H/302I); - a test register comprising a data section and a first test-register selection bit, the first test-register selection bit (304E/304F) being loaded from the first shift-register selection bit (302H/302I); and - a first shift-register multiplexer comprising: - a first input coupled with an output of the first data section; - a second input coupled with a first external data pin; - an output coupled with an input of the second data section; and - a selection input coupled with the first test-register selection bit, the output of the first shift-register multiplexer depending on the first test-register selection bit. - a first input coupled with an output of the first data section; - a second input coupled with a first external data pin; - an output coupled with an input of the second data section; and - a selection input coupled with the first test-register selection bit, the output of the first shift-register multiplexer depending on the first test-register selection bit.